Ebanga

Active Ingredient(s): Ansuvimab-zykl
FDA Approved: * December 21, 2020
Pharm Company: * RIDGEBACK BIOTHERAPEUTICS
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ebanga Overview

Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection.[1][2] The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection.[1] Ansuvimab was approved for medical use in the United States in Decem...

Read more Ebanga Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ansuvimab

Recent Ebanga Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Ansuvimab-zykl or a similar ingredient: (1 result)

• ANSUVIMAB